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Abstract
It has been demonstrated that the HIV-1NL4-3 and IIIBNef alleles downregulate HLA-A and -B but not -C or -E from the cell surface. It remained
elusive, however, whether selective modulation of specific HLA molecules is conserved between different groups of human and simian
immunodeficiency viruses, respectively. To address this, we analyzed a large panel of primate lentiviral Nef proteins andwe found that this property is
conserved among nef alleles from theM, N andO groups of HIV-1, as well as those from SIVcpz, the precursor of HIV-1, and a variety of other highly
divergent primate lentiviruses. In conclusion, our data indicate that Nef's ability to selectively downregulate HLA-A and -B alleles to prevent CTL
lysis and NK killing of virally infected cells is conserved among different primate lentiviral lineages and preceded the zoonotic transmission of
SIVcpz from chimpanzees to humans.
© 2007 Elsevier Inc. All rights reserved.Keywords: HIV; SIV; HLA; Alleles; Nef; CTL lysis; NK killingIntroduction
Downmodulation of class I major histocompatibility com-
plex molecules (MHC-I) is one of the best established functions
of the accessory Nef protein of primate lentivirures (Akari et al.,
2000; Le Gall et al., 1997, 2000; Schwartz et al., 1996). It has
been demonstrated that Nef-mediated removal of MHC-I from
the cell surface protects HIV-1-infected cells against killing by
cytotoxic T lymphocytes (CTLs) (Collins et al., 1998; Yang
et al., 2002). Nef alleles isolated from HIV-1-infected indivi-
duals early in infection are frequently more effective in MHC-I
downmodulation than those obtained from late stage AIDS
patients (Carl et al., 2001), supporting an important role of Nef-
mediated immune evasion in the progression to AIDS (reviewed
in Collins and Baltimore, 1999; Desrosiers, 1999; Doms and⁎ Corresponding author. Fax: +49 731 50065131.
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doi:10.1016/j.virol.2007.11.019Trono, 2000). Experiments with specific simian immunodefi-
ciency virus (SIV) Nef mutants demonstrated that efficient
MHC-I downmodulation is associated with a strong selective
advantage in infected rhesus macaques (Münch et al., 2001;
Swigut et al., 2004), confirming that this function is important
for viral immune evasion and effective persistence in vivo.
Multiple studies have analyzed the mechanism(s) of Nef-
mediated downmodulation of MHC-I. Altogether, they suggest
that Nef binds to the cytoplasmic tail of MHC-I (Williams et al.,
2002) and utilizes at least two pathways to reduce its expression
on the cell surface: (i) recruitment of AP-1 to the MHC-I
cytoplasmic tail to re-routeMHC-I from the trans-Golgi network
(TGN) to lysosomes and (ii) endocytosis of MHC-I from the
plasma membrane to the TGN in a PACS-1, AP-1 and clathrin-
dependent manner (Blagoveshchenskaya et al., 2002; Kasper
and Collins, 2003; Kasper et al., 2005; Larsen et al., 2004; Le
Gall et al., 1998; Lubben et al., 2007; Mangasarian et al., 1999;
Piguet et al., 2000; Roeth et al., 2004). However, the exact
230 A. Specht et al. / Virology 373 (2008) 229–237mechanisms and the relative contribution of these pathways to
MHC-I downmodulation are controversial (reviewed in Roeth
and Collins, 2006). Moreover, the magnitude of the effects may
be cell type dependent, possibly because Nef inhibits export and
increases turnover of MHC-I in HIV-1-infected T cells but
mainly affects endocytosis in other cell types commonly used to
study Nef function, such as HeLa-derived cell lines (Kasper and
Collins, 2003; Kasper et al., 2005).
Reduced cell surface levels of MHC-I are beneficial for HIV-
1 in avoiding CTL recognition but could increase the sus-
ceptibility of virally infected cells to lysis by natural killer (NK)
cells. An elegant study by Cohen et al. (1999), however, has
demonstrated that the HIV-1 Nef protein protects infected cells
against both CTLs and NK cells by affectingMHC-I cell surface
expression in a selective manner, i.e. it specifically down-
modulates HLA-A and -B but not HLA-C or -E alleles. This
selectivity most likely allows HIV-1 to balance escape fromCTL
lysis with protection from NK attack and is presumably
important for effective viral immune evasion and persistence.
It has been established that a large variety of HIV-1, HIV-2 and
SIV Nef alleles downmodulate human MHC-I from the surface
of infected T cells (Kirchhoff et al., 2004; Münch et al., 2005;
Schindler et al., 2006). Selective downmodulation of specific
HLA molecules, however, has only been demonstrated for nef
alleles of the T cell line adapted HIV-1 group M subtype B NL4-
3 and IIIB strains (Adnan et al., 2006; Cohen et al., 1999;
Williams et al., 2002).
Results and discussion
To assess whether selective downmodulation of HLA-A and
HLA-B is conserved between different groups of HIV-1 and
other primate lentiviruses, we generated Jurkat Tcell lines stably
expressing the ectodomain of the CD8α chain fused to the
cytoplasmic domains of HLA-A, -B, -C or E. The predicted
amino acid sequences for the cytoplasmic domains of these HLA
alleles and the position of the Y320, A323 and D327 residues in
HLA-A and -B, known to be critical for Nef interaction (Cohen
et al., 1999; Williams et al., 2002), are indicated in Fig. 1. A total
of 23 HIV-1 and SIV nef alleles was selected for functional
analysis based on their species-origin and phylogenetic relation-
ship (Schindler et al., 2006). This set encompassed the HIV-1 M
and N groups, which arose from independent transmissions of
SIVcpz from the Pan troglodytes troglodytes (P.t.t.) subspecies
of chimpanzees to humans (reviewed in Hahn et al., 2000); HIV-
1 group O, that is most closely related to SIVs found in gorillasFig. 1. Alignment of MHC-I cytoplasmic domain sequences. Dots indicate
amino acid identity and the positions critical for Nef interaction are shaded
(6, 32). The numbering corresponds to the amino acid position in HLA-Cw4 (6).(Van Heuverswyn et al., 2006); SIVcpz from both P.t.t. and the
Pan troglodytes schweinfurthii (P.t.s.) subspecies that has not
been found in humans (Hahn et al., 2000), and a variety of SIVs
from different primate lentiviral lineages. Notably, the great
majority of SIVcpz nef alleles were obtained directly from
uncultured chimpanzee material, such as the spleen (US), PBMC
(GAB2 and Ch-Ni), plasma (Ch-No) and feces (TAN1, TAN2
and TAN3) (Kirchhoff et al., 2004; Takehisa et al., 2007). Thus,
they do not contain changes representing adaptation to human
cells.
To examine whether residues proposed to be critical for
MHC-I downmodulation are conserved, we aligned the amino
acid sequences of the Nef alleles selected for detailed analysis.
The alignment revealed substantial variation in the M20 residue,
the acidic region and the proline-rich motif, which have been
implicated in MHC-I downmodulation by HIV-1 Nef (Blago-
veshchenskaya et al., 2002; Greenberg et al., 1998; Mangasarian
et al., 1999). For example, M20 (numbering corresponds to the
position in the NL4-3 Nef) in the amino-terminal-proximal α-
helix is conserved in HIV-1 Nefs but not in those of SIV (Fig. 2).
The acidic region (EEEE65), proposed to represent a PACS-1
binding site (Piguet et al., 2000), is conserved in HIV-1 group M
and N Nefs but variable in all remaining Nef sequences,
although a minimum of two negatively charged residues is
always preserved at this location (Fig. 2). It is controversial
whether PACS-1 is required for Nef-mediated rerouting of
MHC-I to the trans-Golgi network (Blagoveshchenskaya et al.,
2002; Lubben et al., 2007; Piguet et al., 2000). The proline-rich
motif (PXXP)3 implicated in binding of cellular kinases and
MHC-I modulation (Greenberg et al., 1998; Yamada et al., 2003)
is preserved in HIV-1 and SIVcpz Nefs. However, the last
proline is changed to aspartic acid or glutamine in many SIV
Nefs (Fig. 2). Similarly, a thioesterase binding site (FPD123),
known to be critical for multiple HIV-1 Nef functions including
MHC-I downmodulation (reviewed in Ref. Roeth and Collins,
2006), is conserved in SIVcpz but altered in the remaining SIV
Nef sequences. Thus, the domains previously implicated in
MHC-I downmodulation and binding by HIV-1 Nef show
substantial variation among the HIV-1 and SIV Nef sequences
investigated.
In agreement with the results of previous studies (Kirchhoff
et al., 2004; Münch et al., 2005; Schindler et al., 2006), the great
majority of HIV-1 and SIVcpz Nef alleles efficiently down-
regulated MHC-I (examples shown in Fig. 3A, upper panel). Our
analysis demonstrated that all HIV and SIVcpz nef alleles
specifically downmodulate CD8-HLA-A and -B, but not CD8-
HLA-C or -E fusions (Figs. 3A, B). This effect was Nef-specific
because infection with otherwise isogenic reporter viruses
containing disrupted nef genes did not affect MHC-I or CD8-
HLA fusion expression levels (Fig. 3A, lane 2). Unexpectedly, the
HIV-1 O 8161 Nef allele moderately upregulated CD8-HLA-C
surface expression (Figs. 3A, lane 5 and B). To quantify the
efficiency of receptor modulation, the red mean fluorescence
intensity (MFI) of cells infected with the nef defective control
virus was divided by the MFI of cells infected with reporter
viruses coexpressing Nef and eGFP. In agreement with the results
of Cohen et al. (1999), the NL4-3 Nef downmodulated CD8
Fig. 2. Alignment of HIV-1 and SIV Nef sequences. The NL4-3 sequence is shown in the upper panel for comparison. The M20 residue, the acidic region and the proline-rich domain, which have all been implicated in
MHC-I downmodulation are boxed and shaded and some conserved sequence elements in Nef, as well as the position of the polypurine tract (PPT) and the start of the 3′ long terminal repeat (LTR) are also indicated. Dots
indicate identity with the NL4-3 Nef sequence, dashes indicate gaps introduced to optimize the alignment and asterisks stop codons. Abbreviations: bdg, binding; VIH, catalytic subunit of vacuolar ATPase.
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233A. Specht et al. / Virology 373 (2008) 229–237chimeras containing the cytoplasmic tails of HLA-A and -B but
not -C or -E (Fig. 3B). The HIV-1 group M NA7, N YBF116 and
O 8161K9 and 13127k2 nef alleles showed a similar phenotype,
whereas the group N YBF30 Nef was generally poorly active in
MHC-I downmodulation (Fig. 3B). Thus, selective downmodu-
lation ofHLA-A and -B is a conserved property of theM,N andO
groups of HIV-1. Similarly, Nef alleles derived from the simian
counterpart of HIV-1, SIVcpz, also downmodulated CD8
chimeras containing the cytoplasmic tails of HLA-A and -B,
but not -C and -E (Fig. 3B). Notably, the SIVcpz P.t.t. TAN2 nef
allele, amplified directly from fecal viral RNA of a wild
chimpanzee (Takehisa et al., 2007), showed the highest activity
of all nine SIVcpz Nefs analyzed and downmodulated HLA-A
and -B as efficiently as the NL4-3 Nef (compare Fig. 3A, panels 3
and 7). We found that all Nef alleles that efficiently down-
modulated CD8-HLA-A also potently removed CD8-HLA-B
from the cell surface (Fig. 3C, left). Furthermore, modulation of
CD8-HLA-A and -B fusions correlated with that of MHC-I (Fig.
3C). Altogether, our data demonstrate that SIVcpzNefs fromboth
subspecies of chimpanzees selectively downmodulate HLA-A
and -B without adaptive changes. This result is not unexpected
because molecules of the HLA-A, -B and -C loci and chimpanzee
Patr (Pan troglodytes) -A, -B and -C 1oci share identical
cytoplasmic domain sequences. The cytoplasmic domains of
HLA-E and Patr-E are also very similar. However, the Patr-E tail
is 8 amino acids shorter than HLA-E and has a G to R change at
position 319 (Fig. 1).
To exclude the possibility that the effect of the Nef alleles
analyzed on the CD8-HLA chimeras may not correspond exactly
to downmodulation of unaltered HLA molecules, we also
examined 721.221 cells expressing different MHC-I types
(Cohen et al., 1999) infected with the various HIV-1 Nef
recombinants. Staining of the cells for flow cytometric analysis
was performed with PE-conjugated mouse monoclonal antibody
to a conserved determinant common to HLA-A, -B and -C
molecules. This analysis confirmed the results obtained using
the CD8-HLA-fusions and showed that HIV-1 groups M, N and
O, as well as SIVcpz nef alleles all downmodulate HLA-A and
-B, but not -C from the cell surface (examples shown in Fig. 4A).
The data also verified that the HIV-1 O 8161 nef allele
moderately upregulates HLA-C (see Figs. 4A, lane 5 and B).
Quantitative assessment of HLA downmodulation revealed that
HIV-1 and SIVcpz nef alleles downmodulate human HLA-A
and -B with similar efficiencies (Fig. 4B). Predictably, down-
modulation of HLA-A and -B correlated with each other; with
that of CD8-HLA fusions and with MHC-I (Fig. 4C). In
agreement with the results of Cohen et al. (1999), down-
modulation of HLA-A by HIV-1 Nefs was usually slightly more
efficient than that of HLA-B (Fig. 4B).
Finally, we analyzed nef alleles from several highly divergent
primate lentiviruses, including SIVrcm from Red-cappedFig. 3. HIV-1 and SIVcpz Nef alleles selectively downmodulate CD8 molecules fuse
parental Jurkat T cell line and derivatives thereof stably expressing CD8 fusions cont
HIV-1 recombinants expressing eGFP alone or together with the nef alleles indic
downmodulation are indicated. (B) Quantitative assessment of Nef-mediated downm
shown in panel A. (C) Correlation of the efficiencies of Nef-induced HLA-A and HMangabeys (Cercocebus torquatus), as well as SIVgsn and
SIVmus from Greater spot-nosed and Mustached monkeys
(Cercopithecus nictitans andmona, respectively). The precursor
of SIVrcm most likely recombined with that of SIVgsn/mus in
chimpanzees to generate SIVcpz (Bailes et al., 2003). Notably, it
has been shown that the SIVcpz nef was entirely derived from
SIVrcm (Schindler et al., 2006). However, the available SIVrcm
15 and GB1 nef alleles did not efficiently downmodulate MHC-I
(Fig. 5A, and data not shown), although the GB1 Nef removes
human CD4 and TCR-CD3 from the cell surface (Schindler
et al., 2006). Thus, it will be interesting to further analyze
whether the inability of both SIVrcm Nefs to downmodulate
humanMHC-I is merely coincidence for these particular isolates
or whether adaptive changes are required to interact more
efficiently with MHC class I leukocyte antigens from humans
and chimpanzees. We have previously shown that SIVgsn and
SIVmus Nef alleles downmodulate human MHC-I (Schindler
et al., 2006). Although they are highly divergent from those of
HIV-1 and SIVcpz (Fig. 2), they also selectively down-
modulated CD8-HLA-A and -B but not -C and -E (Fig. 5A).
The SIVsyk, SIVblu and SIVagm sab1 nef alleles from Sykes,
Blue and African green monkeys showed a similar phenotype. In
comparison, nef genes from SIVrcm, SIVdeb, SIVsun and
SIVagm tan1, from Red-capped mangabeys, De Brazza, Sun-
tailed and Tantalus monkeys, respectively, displayed little if any
effect on surface expression of CD8-HLA fusions. Flow
cytometric analysis of infected 721.221 cells confirmed that
nef alleles from different groups of primate lentiviruses
selectively reduce HLA-A and -B but not -C surface expression
(data not shown). The potency of these nef alleles in down-
modulating CD8-HLA-A or -B fusions as well as unaltered
HLA-A or HLA-B molecules correlated with their ability to
downregulate MHC-I (Figs. 5B and data not shown). However,
several nef alleles that had neglectable effects on CD8-HLA-A
and -B fusions clearly downmodulated MHC-I from the cell
surface. Thus, in addition to the sequence of the cytoplasmic
domain, other parameters, such as endocytosis, recycling rates
and/or protein stability, may also effect the efficiency of HLA
modulation by Nef.
In summary, our data suggest that the strategy to selectively
downregulate specific MHC-I molecules from the cell surface to
evade CTL recognition –while leaving others on the cell surface
to prevent NK cell attack – is conserved between all groups of
HIV-1, its simian counterpart SIVcpz and many other primate
lentiviruses. Thus, despite the high sequence variability of
primate lentiviral Nefs, their ability to interact specifically with
the cytoplasmatic tail of HLA-A and -B molecules seems well
conserved. It remains to be determined whether the divergent
motifs previously implicated in Nef-mediated MHC-I down-
modulation still perform their proposed functions, whether
changes elsewhere in Nef can compensate for mutations in thesed to the cytoplasmic tail of HLA-A and -B. (A) Flow cytometric analysis of the
aining the cytoplasmic tails of the indicated HLA types. Cells were infected with
ated. The range of eGFP expression and the MFIs used to calculate receptor
odulation of the indicated CD8-HLA chimeras. Examples of primary data are
LA-B downmodulation between one another and with that of MHC-I.
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Fig. 5. Selective downmodulation of HLA-A and -B is conserved between highly divergent primate lentiviruses. (A) Quantitative assessment of Nef-mediated
downmodulation of MHC-I and of the indicated CD8-HLA chimeras. (B) Correlation of the efficiency of Nef-induced CD8-HLA-A downmodulation with that of
MHC-I.
235A. Specht et al. / Virology 373 (2008) 229–237regions, and/or whether the same function can be mediated by
alternative regions in different Nef alleles. The latter was
described for the SIVcpz/HIV-1 and SIVsmm/HIV-2/SIVmac
lineages, which apparently use different surfaces of Nef to
downmodulate MHC-I (Swigut et al., 2000). Nevertheless, most
HIV-2 and SIVsmm Nefs also selectively downmodulate HLA-
A and -B (DeGottardi, Specht, Kirchhoff and Evans, unpub-
lished observations). Our results also show that some nef alleles,
i.e. those of HIV-1 O 8161 and SIVgsn, moderately enhance
HLA-C surface expression, possibly to improve protection
against NK cells. Thus, the mechanisms that primate lentiviruses
have evolved to avoid the antiviral immune response are even
more sophisticated than previously anticipated. It will be
interesting to assess whether individuals infected with HIV-1
strains that promote HLA-C expression show strong NK and
weak HLA-C responses.
Methods
CD8-HLA fusions
CD8α chain sequences coding for residues 1–208 were
amplified by PCR using the forward primer 5′-GCGGATC-
CGTCGCCACCATGGCCTTACCAGTGACC-GCCTTGC
and the reverse bridge primers designed with a 16 bp in-frame
overlap with HLA class I sequences; HLA-A, 5′-CTGAGC-
TCTTCCTCCTGTGGTTGCAGTAAAG-3′; HLA-B, 5′-CCT-
GAACTCTTCCTCCTGTGGTTGCAGTAAAG-3′; HLA-C,
5′-CCACCTGAGC-TCTTCCTCCTGTGGTTGCAGTAA-
AG-3′; HLA-E, 5′-CCTGAGCTCTTCTTCCTGTG-GTTG-
CAGTAAAGG-3′. HLA class I sequences were generated by
PCR using the following overlapping primer pairs HLA-A; 5′-
AGGAGGAAGAGCTCAGATAGAAAAGGAGGG-AGC-
TACTCTCAGGCTGCAAGCAGTGACAGTGCCCAG-3′
and 5`-GCGAATTCTCACA-CTTTACAAGCTGTGAGAGA-Fig. 4. Selective downmodulation of specific MHC-I molecules is a conserved propert
MHC-I types were infected with HIV-1 Nef/eGFP constructs coexpressing eGFP and
analysis. The range of eGFP expression used to calculate receptor downmodulation an
in stably transfected 721.221 cells. (C) Correlation between Nef-mediated downmo
MHC-I downregulation.CACATCAGAGCCCTGGGCACTGTCACT-3′; HLA-B; 5`-
AGGAGGAAGAGTTCAGGTGGAAAAGGAGGGAG-
CTACTCTCAGGCTGCGTCC-AGCGACAG-3′, and 5`-
GCGAATTCTCAAGCTGTGAGAGACACATCAGA-
GCCCTGG-GCACTGTCGCTGGACGCAGC-3′; HLA-C;
5`-AGGAGGAAGAGCTCAGGTGGAAAA-GGAGG-
GAGCTGCTCTCAGGCTG-CGTCCAGCAACAGTGCC-3′
and 5`-GCGAATTCT-CAGGCTTTACAAGCGATGAGA-
GACTCATCAGAGCCCTGGGCACTGTTGCTGGAC-3`;
and HLA-E; 5`-AGGAAGAAGAGCTCAGGTGGAAA-
AGGAGGGAGCTACTCTAA-GGCTGAGTGG-3′ and 5′-
TTACAAGCTGTGAGACTCAGACCCCTGGGCACTGTC-
GC-TCCACTCAGCCTTAGAG-3′. CD8α and HLA class I
sequences were joined in a second round of PCR using forward
and reverse primers that included BamHI and EcoRI restriction
sites. The final CD8-HLA class I cDNA products were digested
with BamHI and EcoRI and cloned into the multiple cloning
site of pQCXIN (BD Biosciences).
Stable transformed Jurkat T cells
Jurkat T cell lines expressing the extracellular and transmem-
brane domains of the CD8α chain (residues 1–208) fused to
different HLA class I cytoplasmic tail sequences were estab-
lished by retroviral transduction. CD8-HLA class I expression
constructs were packaged into VSV G pseudotyped MLV
particles by cotransfection of GP2 293T cells with each of the
pQCXIN constructs described above and pVSV G (BD
Biosciences). Culture supernatant was collected 48 h post-
transfection, clarified by centrifugation and filtered though a
0.45 μm membrane. Jurkat cells (1×106) were transduced with
0.1 ml GP2 293T supernatant for 2 h then brought up in 2ml
RPMI medium supplemented with 10% FBS, L-glutamine,
penicillin and streptomycin. Selection was started 3 days after
infection by the addition of G418 (500 μg/ml). After 3–4 weeks,y of HIV-1 and SIVcpz Nef proteins. (A) 721.221 cells stably expressing defined
the indicated nef alleles or eGFP alone (nef−) were examined by flow cytometric
d theMFIs is indicated. (B) Nef-mediated downmodulation of HLA-A, -B and -C
dulation of CD8-HLA-fusions and the corresponding HLA molecules and with
236 A. Specht et al. / Virology 373 (2008) 229–237G418 resistant cells were stained with the PE-conjugated anti-
CD8 monoclonal antibody RPA-T8 (BD Pharmingen). Cells
with the highest levels of CD8 surface expression (top 5%)
were enriched by FACS and expanded for analysis of Nef
downregulation.
Proviral constructs
The generation of infectious NL4-3 proviral constructs
coexpressing Nef and eGFP via an internal ribosome entry site
(IRES) and the nef defective control constructs containing a
stop codon at position 40 of the NL4-3 nef ORF either alone
(nef⁎) or combined with a second stop codon at position 3 and a
mutation of the initiation codon (nef−) has been described
previously (Schindler et al., 2005; 2006).
Cell lines and virus stocks
Jurkat, 721.221 and 293T cells were cultured as described
previously (Cohen et al., 1999; Münch et al., 2005; Kirchhoff
et al., 2004). To generate viral stocks, 293T cells were
cotransfected with the HIV/SIV Nef/eGFP constructs and a
plasmid (pHIT-G) expressing the Vesicular Stomatitis Virus G
protein (VSV G) (Schindler et al., 2003). The latter was used to
achieve high initial infection levels for functional analysis.
However, all HIV-1 constructs contained intact env genes and
were thus replication-competent following the first round of
infection. Virus stocks were quantified using a p24 antigen
capture assay provided by the NIH AIDS Research and
Reference Reagent Program.
Flow cytometric analysis
Jurkat or 721.221 cells were transduced with HIV-1 NL4-3
constructs coexpressing Nef and eGFP and cell surface ex-
pression of MHC-I or CD8-HLA fusions was measured about
48 h post-transduction by staining with red fluorescently
conjugated MHC-I or a monoclonal mouse anti-human CD8
phycoerythrin-conjugated antibody (Caltag) as described pre-
viously (Schindler et al., 2006). For quantification of Nef-
mediated modulation of specific surface molecules, the levels of
receptor expression (red fluorescence) were determined for cells
expressing a specific range of eGFP (Schindler et al., 2003;
Kirchhoff et al., 2004). The extent of downmodulation or
induction (n-fold) was calculated by dividing the MFI obtained
for cells infected with the nef-minus NL4-3 control viruses by
the corresponding values obtained for cells infected with viruses
coexpressing nef and eGFP.
Nucleotide sequence accession numbers
The nef sequences analyzed in this study have been
previously deposited in the GenBank database and can be
retrieved by using the following accession numbers: M19921
(NL4-3), DQ242535 (NA7), AY536905 (MVP8161),
AY536904 (MVP13127), AJ006022 (YBF30), AY536907
(YBF116), AY536908 (US), AY536911 (Cam5k2), AF382828(GAB2), EF394356 (TAN1.910), DQ374657 (TAN2.69),
DQ374658 (TAN3.1), AF468659 (SIVgsn CM166),
AY340700 (SIVmus CMS1085) (SIVrcm GB1), AY523865
(SIVdeb CM40), DQ222473 (SIVsyk KE44), AY523867
(SIVsyk KE51), DQ222474 (SIVblu KE31), DQ222476
(SIVsun sol-36), AF395566 (SIVtan 1), U04005 (SIVsab 1).
Statistical analysis
The mean activities of different groups of nef alleles were
compared using Student's t test. Similar results were obtained
with the Mann–Whitney test. The PRISM package version 4.0
(Abacus Concepts, Berkeley, CA) was used for all calculations.
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